Oncology Key Account Director - Biosimilars Market Access
Celltrion USA
Los Angeles (CA)
On-site
USD 120,000 - 160,000
Full time
14 days+
Application generator
An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Get past ATS filters
Job summary
A biopharmaceutical company based in Los Angeles, California is seeking a Key Account Director (KAD) Sales - Oncology. This role involves strategic engagement with Integrated Delivery Systems and health systems to enhance the launch and adoption of innovative therapies. Candidates should have over 10 years of experience in the pharmaceutical industry, with a strong background in biologics and biosimilars, coupled with excellent communication and analytical skills. Flexibility and teamwork are essential as the role requires travel up to 50% of the time.
Qualifications
Minimum of 10 years of experience in Pharma-Commercial, pre-launch launch, and post-launch of products.
Ability to travel 50% of the time.
Solid business acumen to interpret territory data for call planning.
Responsibilities
Develop and implement comprehensive business plans tailored to key accounts.
Establish and maintain relationships with key decision-makers and stakeholders.
Analyze trends and provide regular reports on key account metrics.
Skills
Biologics knowledge
Biosimilars experience
Communication skills
Analytical skills
Interpersonal skills
Education
Bachelor’s Degree in business or related field
MBA or advanced degree
Job description
A biopharmaceutical company based in Los Angeles, California is seeking a Key Account Director (KAD) Sales - Oncology. This role involves strategic engagement with Integrated Delivery Systems and health systems to enhance the launch and adoption of innovative therapies. Candidates should have over 10 years of experience in the pharmaceutical industry, with a strong background in biologics and biosimilars, coupled with excellent communication and analytical skills. Flexibility and teamwork are essential as the role requires travel up to 50% of the time.